485 results on '"Beauval, Jean-Baptiste"'
Search Results
2. Active surveillance for low-risk prostate cancer with high tumor burden at biopsy: lessons learned from a contemporary radical prostatectomy cohort
3. Patient experience and satisfaction after same-day discharge radical prostatectomy using a personalized, digital perioperative programme
4. Open versus robotic partial nephrectomy in obese patients: a multi-institutional propensity score-matched analysis (UroCCR 43—Robese study)
5. Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablation
6. Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1)
7. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?
8. Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes
9. What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
10. Multidisciplinary real-world management of metastatic castration-sensitive prostate cancer: A French national study (PROFILE study)
11. Preparing for the Worst: Management and Predictive Factors of Open Conversion During Minimally Invasive Renal Tumor Surgery (UroCCR-135 Study)
12. Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study)
13. Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach
14. Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis
15. Partial nephrectomy in solitary kidneys: comparison between open surgery and robotic-assisted laparoscopy on perioperative and functional outcomes (UroCCR-54 study)
16. Evaluation of oncological outcomes of robotic partial nephrectomy according to the type of hilar control approach (On-clamp vs Off-clamp), a multicentric study of the French network of research on kidney cancer—UROCCR 58-NCT03293563
17. Magnetic Resonance Imaging–based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification
18. Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions
19. Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens
20. Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?
21. PD45-05 WHEN DOES SYSTEMATIC BIOPSY INFORMATION MATTER THE MOST? IDENTIFYING INDEPENDENT PREDICTORS OF DISEASE DOWNGRADING AT RADICAL PROSTATECTOMY IN HIGH GRADE PROSTATE CANCER BASED ON A LARGE MULTI-INSTITUTIONAL SERIES
22. MP19-15 THE SIGNIFICANT ADDED VALUE OF CONCOMITANT SYSTEMATIC PROSTATE BIOPSIES IN ADDITION TO TARGETED SAMPLING IN PATIENTS WITH PREVIOUS NEGATIVE BIOPSIES. IMPLICATIONS FOR ACCURATE STAGING PREDICTIONS FROM A LARGE MULTI-INSTITUTIONAL SERIES
23. Same-day discharge surgery for robot-assisted radical prostatectomy in the era of ERAS and prehabilitation pathways: a contemporary, comparative, feasibility study
24. Impact of Hospital volume on postoperative outcomes after radical prostatectomy: A 5-Year nationwide database analysis
25. Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
26. Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic)
27. From an On-site Program to a Mobile App for Prehabilitation and Rehabilitation for Robotic Radical Prostatectomy: Lessons Learned from 5 Years of Experience, the COVID-19 Outbreak, and Comparison with Nationwide Data
28. Patient Compliance to a Perioperative Digital Platform for Pre- and Rehabilitation Programs, Outcomes Reporting, and Remote Monitoring After Surgery: A Pilot Study
29. Label-Free SERS of Urine Components: A Powerful Tool for Discriminating Renal Cell Carcinoma through Multivariate Analysis and Machine Learning Techniques
30. Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions
31. The prognostic value of high-grade prostate cancer pattern on MRI-targeted biopsies: predictors for downgrading and importance of concomitant systematic biopsies
32. Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer
33. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging–targeted Biopsy
34. Robotic-assisted kidney transplantation in obese recipients compared to non-obese recipients: the European experience
35. Patient experience and satisfaction after same-day discharge radical prostatectomy using a personalized, digital perioperative programme.
36. PARP inhibitors in prostate cancers, is it time for combinations?
37. Salvage Radical Prostatectomy for Recurrent Prostate Cancer: A Systematic Review (French ccAFU)
38. Postoperative outcomes of elderly patients undergoing partial nephrectomy
39. Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery
40. Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study
41. Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance
42. Intraoperative Cyst Rupture during Partial Nephrectomy for Cystic Renal Masses—Does it Increase the Risk of Recurrence?
43. Loco-regional treatment for castration-resistant prostate cancer: Is there any rationale? A critical review from the AFU-GETUG
44. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study
45. Management of urinary-tract fistulas using reversible balloon nephrostomy: a single-center retrospective analysis of 56 patients
46. The BETTY Score to Predict Perioperative Outcomes in Surgical Patients
47. Comparison of generic and specific anxiety in patients treated with apalutamide plus active surveillance vs active surveillance alone for low and intermediate risk prostate cancer.
48. Progrès dans l’étude du cancer de la prostate : la culture cellulaire en trois dimensions reproduit ex vivo les caractéristiques des tumeurs prostatiques
49. Systemic treatments for high-risk localized prostate cancer
50. Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.